Pemetrexed Continuation Maintenance versus Conventional Platinum-based Doublet Chemotherapy in EGFR-negative Lung Adenocarcinoma: Retrospective Analysis

被引：0
|
作者：
Hwang, I. K. [1 ]
Paik, S. S. [1 ]
Park, M. J. [2 ]
Lee, S. H. [2 ]
机构：
[1] Dongnam Inst Radiol & Med Sci, Dept Internal Med, Busan, South Korea
[2] Kyung Hee Univ, Med Ctr, Dept Internal Med, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
pemetrexed; chemotherapy; Platinum;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03-020
引用
收藏
页码：S2134 / S2134
页数：1
相关论文
共 50 条
  • [1] Pemetrexed Continuation Maintenance versus Conventional Platinum-Based Doublet Chemotherapy in EGFR-Negative Lung Adenocarcinoma: Retrospective Analysis
    Paik, Seung Sook
    Hwang, In Kyoung
    Park, Myung Jae
    Lee, Seung Hyeun
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2018, 81 (02) : 148 - 155
  • [2] Impact of platinum/pemetrexed combination versus other platinum-based regimens on adjuvant chemotherapy in resected lung adenocarcinoma
    Zhai, Xiaoyu
    Zheng, Qiwen
    Yang, Lu
    Zhu, Yixiang
    Li, Junling
    Liu, Yutao
    Wang, Ziping
    SCIENTIFIC REPORTS, 2017, 7
  • [3] Impact of platinum/pemetrexed combination versus other platinum-based regimens on adjuvant chemotherapy in resected lung adenocarcinoma
    Xiaoyu Zhai
    Qiwen Zheng
    Lu Yang
    Yixiang Zhu
    Junling Li
    Yutao Liu
    Ziping Wang
    Scientific Reports, 7
  • [4] Impact of Platinum/Pemetrexed versus Other Platinum-Based Regimens on Adjuvant Chemotherapy in Resected Adenocarcinoma Lung Cancer
    Zhai, Xiaoyu
    Wang Ziping
    Yang, Lu
    Zhu, Yixiang
    Li, Junling
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S930 - S931
  • [5] Effect of platinum-based chemotherapy on EGFR gene mutation status in lung adenocarcinoma
    Wang, Yuli
    Ma, Xinyu
    Wei, Yuan
    Ma, Di
    Gong, Ping
    MEDICINE, 2018, 97 (04)
  • [6] The Efficacy of Platinum-Based Chemotherapy as Adjuvant Therapy in EGFR Mutant Lung Adenocarcinoma
    Onodera, K.
    Aokage, K.
    Wakabayashi, M.
    Ikeno, T.
    Suzuki, J.
    Miyoshi, T.
    Tane, K.
    Smajima, J.
    Tsuboi, M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S199 - S200
  • [7] Comparison of the efficacy and tolerability of gefitinib with pemetrexed maintenance after first-line platinum-based doublet chemotherapy in advanced lung adenocarcinoma: single-center experience
    Lin, Liping
    Zhao, Juanjuan
    Hu, Jiazhu
    Huang, Fuxi
    Han, Jianjun
    He, Yan
    Cao, Xiaolong
    ONCOTARGETS AND THERAPY, 2016, 9 : 6305 - 6314
  • [8] Pemetrexed versus best supportive care following platinum-based doublet chemotherapy for patients with advanced nonsmall cell nonsquamous lung cancer
    Kumari, P.
    ANNALS OF ONCOLOGY, 2017, 28 : 139 - 139
  • [9] COMPARISON OF GEFITINIB AND PLATINUM-BASED CHEMOTHERAPY AND ONLY PLATINUM-BASED CHEMOTHERAPY TO TREAT LUNG ADENOCARCINOMA
    Yang, L.
    Fan, J. H.
    Liu, L. L.
    Su, Y.
    Lu, D.
    Huang, J. Y.
    Zhang, H.
    Li, Y.
    Huo, H. D.
    Du, Z. H.
    Liu, G. T.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2018, 32 (03): : 613 - 618
  • [10] Icotinib versus docetaxel used in lung adenocarcinoma patients who failed platinum-based chemotherapy: a retrospective study
    He, Wei
    Zhang, Yan
    Xiong, Yu
    Dai, Feng-juan
    Fan, Qing-xia
    ONCOTARGETS AND THERAPY, 2016, 9 : 4037 - 4041
12345